DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Hanauer SB, Feagan BG, Lichtenstein GR. et al.
Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial.
Lancet 2002; 359: 1541-1549
We do not assume any responsibility for the contents of the web pages of other providers.